Gabify, a healthtech startup focused on solving neurodevelopmental challenges in children, has raised $175,000 in a pre-seed funding round led by Inflection Point Ventures (IPV).
The startup has also been awarded Rs 25 lakh under the Nidhi Seed Support Scheme by GHRTBI (G H Raisoni Technology Business Incubator Foundation), a government-backed initiative that supports early-stage startups with high innovation potential.
It will be using the raised capital for clinical validation, technology enhancement, and team expansion, key priorities aimed at accelerating growth and building a sustainable revenue model.
Gabify is also part of the 4th cohort of IPV IdeaSchool, an exclusive cohort-based incubator programme designed for pre-Seed to seed-stage startups.
Founded in 2023 by Sahil Chopra, Prachi Sood, and Vasyl Leshchuk, Gabify is building what it claims India’s first AI-powered platform for early screening and therapy management of speech and neurodevelopmental disorders.
The startup has an end-to-end AI screening and therapy platform specifically designed for speech and neurological disorders such as Autism and ADHD. Its use of dual-AI (voice + vision) provides a comprehensive view of the child’s speech patterns as well as facial expressions, eye gaze, and behaviours based on 189+ clinically validated criteria that are aligned with DSM-5 and CARS.
Gabify claims that the system employs a human-in-loop (HITL) approach for clinical validation to review all AI-based clinical outputs to ensure they are accurate and reflect expert professional input.
“Working with Inflection Point Ventures has been a deeply collaborative experience. Beyond capital, IPV brings strategic insight, credibility, and a strong founder-first mindset. Our goal with Gabify is to ensure that no child is left behind simply due to delayed diagnosis or lack of access. We are building technology that empowers clinicians, supports parents, and gives every child a fair chance at early intervention and a better future,” said Sahil Chopra, Founder & CEO, Gabify.
Ankur Mittal, Co-founder, Inflection Point Ventures, said, “Addressing neurodevelopmental challenges at an early stage plays a critical role in shaping a child’s future, yet it remains one of the most underserved areas in the healthcare ecosystem. Gabify is tackling this gap through a strong blend of clinical validation and AI-led innovation, enabling faster and more accurate identification of developmental conditions.”
“Their approach has the potential to significantly reduce diagnosis timelines, improve intervention outcomes, and expand access to quality care for families and clinicians alike. At Inflection Point Ventures, we are excited to support Gabify as they work toward transforming early detection and intervention pathways through scalable, technology-driven solutions, both in India and globally. We look forward to leveraging our network and strategic expertise to help the company accelerate its growth journey.”
